2002
DOI: 10.1093/ajcn/75.2.275
|View full text |Cite
|
Sign up to set email alerts
|

5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women

Abstract: The response to tHcy-lowering therapy is influenced by MTHFR genotype. Women with the TT genotype seem to benefit the most from supplementation with either FA or MTHF. In women with the CT or CC genotype, FA is more effective than MTHF in lowering plasma tHcy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
48
2
4

Year Published

2002
2002
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 99 publications
(58 citation statements)
references
References 31 publications
4
48
2
4
Order By: Relevance
“…This study, which comprised equal numbers of subjects with each MTHFR C677T genotype (n ¼ 42 of each), supports previous observations made in cohorts where only a small number of TT homozygotes were studied (Malinow et al, 1997;Nelen et al, 1998). Fohr et al (2002) have recently reported that subjects with the MTHFR TT genotype have a greater response to synthetic folates than other genotypes, but did not include a dietary intervention in their study. The gene frequency of C677T variant MTHFR in South Wales is 0.32, giving genotype frequencies of 12% TT, 40% CT and 48% CC (in keeping with other Caucasian populations; Clark et al, 1998).…”
Section: Discussionsupporting
confidence: 86%
“…This study, which comprised equal numbers of subjects with each MTHFR C677T genotype (n ¼ 42 of each), supports previous observations made in cohorts where only a small number of TT homozygotes were studied (Malinow et al, 1997;Nelen et al, 1998). Fohr et al (2002) have recently reported that subjects with the MTHFR TT genotype have a greater response to synthetic folates than other genotypes, but did not include a dietary intervention in their study. The gene frequency of C677T variant MTHFR in South Wales is 0.32, giving genotype frequencies of 12% TT, 40% CT and 48% CC (in keeping with other Caucasian populations; Clark et al, 1998).…”
Section: Discussionsupporting
confidence: 86%
“…Uma das mais estudadas é a mutação 677C → T no gene da enzima 5,10-metilenotetrahidrofolato redutase (MTHFR), que catalisa a conversão de 5,10-metilenotetrahidrofolato em 5-metiltetrahidrofolato, o co-substrato para metilação da homocisteína a metionina pela enzima metionina sintase. Vários estudos mostram que os portadores do genótipo T/T, quando comparados com portadores dos genótipos C/T ou C/C, apresentam menores níveis de folato plasmático e maiores níveis de homocisteína, especialmente em associação com baixos níveis de folato no plasma (Refsum et al, 2006), e apresentam melhores respostas à suplementação ou à ingestão dietética elevada de folato (Fohr et al, 2002;Silaste et al, 2001). Na gestação, o genótipo materno T/T, principalmente quando associado a um estado inadequado de folato e níveis elevados de homocisteína, aumenta o risco de defeitos do tubo neural nos fetos (Van der Linden et al, 2006).…”
Section: Uso De Indicadores Bioquímicos Na Avaliação Do Estado De Folunclassified
“…As MTHFR is involved in the formation of 5-CH 3 -H 4 folate, this polymorphism could influence the outcome of the study. The proportion of the population homozygous at the T677 MTHFR allele is around 12% (Frosst et al, 1995;Malinow et al, 1997;Fohr et al, 2002). A poor folate status in these individuals leads to higher homocysteine concentrations compared to subjects who are not homozygous for this mutation (Jacques et al, 1996), and they show enhanced response to folic acid supplementation (Malinow et al, 1997).…”
Section: Discussionmentioning
confidence: 99%